CTIS.eu › Cities › Austria › Innsbruck
Innsbruck
Austria
347 total trials
153 recruiting
2025-521917-24-00
5
2026-01-21
Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carci
2024-519404-27-00
5
2026-01-16
IDH-mutant grade 2 or 3 astrocytoma
2025-522683-32-00
5
2026-01-15
Early-Stage Parkinson’s Disease (PD)
2024-512298-28-00
11
2025-12-18
Neovascular age-related macular degeneration
2025-522860-34-00
5
2025-12-16
Chronic lymphocytic leukemia (CLL)
2024-513586-39-00
5
2025-12-10
Prostate Cancer
2025-520896-13-00
5
2025-12-04
Friedreich’s ataxia
2025-521242-26-00
4
2025-11-27
Moderately to Severely Active Ulcerative Colitis
2025-521744-37-00
5
2025-11-17
Mild to moderate major depressive disorder
2025-520555-89-00
5
2025-11-14
Metastatic castration-resistant prostate cancer (mCRPC)
2024-517553-26-00
5
2025-11-12
Advanced ALK-positive non-small cell lung cancer (NSCLC)
2024-519871-24-00
10
2025-11-11
Breast cancer
2025-521564-35-00
4
2025-11-06
ischemic stroke with intracranial large artery occlusion of the anteri
2024-517131-52-00
5
2025-11-03
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lym
2024-516924-32-00
5
2025-10-17
Neovascular Age-Related Macular Degeneration (nAMD)
2025-520490-38-00
3
2025-10-13
Haemophilia A with or without inhibitors. Proposed indication under de
2024-515682-34-00
5
2025-10-06
Chronic migraine
2024-515715-22-00
5
2025-10-06
Episodic migraine
2024-514822-21-00
5
2025-10-02
Platinum-resistant Ovarian Cancer
2024-520210-21-00
5
2025-09-19
Crohn’s Disease
2024-517190-24-00
4
2025-09-16
Peritoneal Cancer
2024-513171-41-00
5
2025-09-11
Vitiligo
2024-516982-35-00
5
2025-09-11
Ovarian Cancer
2024-517167-23-00
5
2025-08-28
Chronic Hepatitis D Infection
Showing 73–96 of 347 trials